Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs

    September 2020 in “ Current Rheumatology Reports
    Roberta Gonçalves Marangoni, Benjamin D. Korman, John Varga
    TLDR Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.
    The document discussed the process of adipocyte-to-mesenchymal transition (AMT), which occurred in multiple organs and diseases and involved transdifferentiation through a precursor cell. This process was reversible and could be influenced by factors such as metabolic stress, myeloid cells, immune dysregulation, and pharmacological intervention. AMT was recognized as a significant process in various forms of fibrosis, and targeting it could have served as a novel approach for treating fibrosis.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results